PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsulcerative colitis
MeSH D003093 - ulcerative colitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D003092:Colitis
0 Companies
0 Drugs
Success rate
D015212:Inflammatory bowel diseases
47 Companies
8 Drugs
$
Success rate
D003093: 
Ulcerative colitis
177 Companies
42 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Salix PharmaceuticalsHydrocortisone Anusol  1984-06-06   
Mesalamine Apriso 2030-05-01 2008-10-31   
TevaPrednisone Prednisone  1982-01-01   
Prednisolone Prednisolone  1999-05-28   
Prednisolone Prelone  1986-02-04   
Mesalamine Mesalamine  2019-05-09   
Hydrocortisone Hydrocortisone  1982-01-01   
Hydrocortisone Nogenic  1988-04-04   
Cortisone Cortisone  1982-01-01   
Nicotine polacrilex Nicotine Polacrilex  2009-02-18   
Methylprednisolone Methylprednisolone  2006-10-27   
Dexamethasone Dexamethasone  1990-08-31   
Novast LaboratoriesMethylprednisolone Methylprednisolone  2019-01-09   
PadagisMesalamine Mesalamine  2004-09-17   
Hydrocortisone Hydrocortisone  1982-01-01   
Hydrocortisone Stie-cort  1985-11-25   
Hydrocortisone, Bacitracin, Neomycin, Polymyxin b Bacitracin-neomycin-polymyxin W/ Hydrocortisone  1982-01-01   
Dexamethasone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Dexamethasone  1989-07-31   
Dexamethasone, Tobramycin Tobramycin Dexamethasone  2022-02-11   
Taro PharmaceuticalPrednisolone Flo-pred 2028-10-11 2008-01-17   
Hydrocortisone butyrate Hydrocortisone Butyrate  2005-08-03   
Hydrocortisone Hydrocortisone  1982-01-01   
Hydrocortisone U-cort  1988-06-13   
Hydrocortisone Hydrocortisone Acetic Acid  1985-03-04   
Glenmark PharmaceuticalsHydrocortisone butyrate Hydrocortisone Butyrate  2013-09-27   
Hydrocortisone Hydrocortisone  2018-10-12   
MylanPrednisone Prednisone  1982-01-01   
Mesalamine Mesalamine  2018-11-20   
Mesalamine Sfrowasa 2027-07-24 1987-12-24   
Olsalazine Dipentum  1990-07-31   
Hydrocortisone, Pramoxine Epifoam  1982-01-01   
Hydrocortisone, Pramoxine Proctofoam  1982-01-01   
Hydrocortisone Cortifoam  1982-02-10   
Dexamethasone Dexamethasone  2008-08-29   
BioconAdalimumab Hulio  2020-07-06   
Johnson & JohnsonUstekinumab Stelara  2009-01-15 $10,865 M Q2/23-Q1/24 
Golimumab Simponi  2009-10-01 $2,213 M Q2/23-Q1/24 
Infliximab Remicade  1998-08-24 $1,653 M Q2/23-Q1/24 
PerrigoHydrocortisone Hydrocortisone  1982-01-01   
Nicotine polacrilex Nicotine Polacrilex  2004-09-16   
1
2
3
4
5
6
...
18
>
Clinical Trials
Historical Success Rate
Phase 1
85%
35/41
Phase 2
43%
43/101
Phase 3
53%
42/79
Approved: 24Overall Success rate: 19%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Dexamethasone,
Hydrocortisone,
Mesalamine,
Methylprednisolone,
Nicotine polacrilex,
Prednisolone,
Prednisolone tebutate,
Prednisone
Padagis
Mesalamine
Mylan
Hydrocortisone,
Nystatin
Johnson & Johnson
Infliximab,
Ustekinumab,
Golimumab,
Benzocaine,
Vitamin k,
Peficitinib,
Retinol
GSK
Nicotine polacrilex,
Hypromellose,
Salicylic acid,
Carmellose,
Carboxymethylcellulose,
Sodium chloride,
ELUBRIXIN,
SOLCITINIB,
Vercirnon,
Microcrystalline cellulose,
Gsk2982772,
Gsk3050002
Sandoz
Adalimumab,
Infliximab,
Mesalamine
Boehringer Ingelheim
Adalimumab
1
2
3
4
5
6
...
12
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use